A detailed history of Legato Capital Management LLC transactions in Insmed Inc stock. As of the latest transaction made, Legato Capital Management LLC holds 36,079 shares of INSM stock, worth $2.54 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
36,079
Previous 45,067 19.94%
Holding current value
$2.54 Million
Previous $3.02 Million 12.79%
% of portfolio
0.35%
Previous 0.42%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$62.0 - $79.01 $557,256 - $710,141
-8,988 Reduced 19.94%
36,079 $2.63 Million
Q2 2024

Jul 26, 2024

SELL
$22.0 - $69.71 $114,202 - $361,864
-5,191 Reduced 10.33%
45,067 $3.02 Million
Q3 2023

Oct 12, 2023

SELL
$19.86 - $26.93 $26,036 - $35,305
-1,311 Reduced 2.54%
50,258 $1.27 Million
Q2 2023

Aug 17, 2023

BUY
$16.44 - $21.1 $239,843 - $307,827
14,589 Added 39.45%
51,569 $1.09 Million
Q4 2022

Feb 01, 2023

BUY
$16.98 - $23.15 $627,920 - $856,087
36,980 New
36,980 $738,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.56B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.